[HTML][HTML] A More Sensitive RQ-PCR to Assess Complete Molecular Remission Does Not Allow the Prediction of Relapse After Discontinuation of Imatinib In Chronic …
FX Mahon, S Dulucq, F Guilhot, L Legros, P Rousselot… - Blood, 2010 - Elsevier
Abstract 2298 We previously reported that imatinib treatment could be safely discontinued in
chronic myeloid leukemia (CML) patients who had achieved a sustained complete …
chronic myeloid leukemia (CML) patients who had achieved a sustained complete …
A More Sensitive RQ-PCR to Assess Complete Molecular Remission Does Not Allow the Prediction of Relapse After Discontinuation of Imatinib In Chronic Myeloid …
FX Mahon, S Dulucq, F Guilhot, L Legros, P Rousselot… - 2010 - ashpublications.org
Abstract 2298 We previously reported that imatinib treatment could be safely discontinued in
chronic myeloid leukemia (CML) patients who had achieved a sustained complete …
chronic myeloid leukemia (CML) patients who had achieved a sustained complete …